Pharmaceuticals and Healthcare Reports China Dyslipidemia Market Cliquez pour lire
  • Commentaires

Pharmaceuticals and Healthcare Reports

China Dyslipidemia Market

Publié sur dans “Santé & Fitness, Santé & Fitness”, langue – English. 3 pages.
More so than in any other market, the statins dominated Chinese dyslipidemia drugs sales in the 2013 base year, contributing 84% to the total market share, reflecting sales of $1.7 billion in total sales Plus
S'abonner GRATUITEMENT

Autres publications de “Pharmaceuticals and Healthcare Reports”

Voir toutes les publications